XYLOCARD 20 mg/ml INTRAVEINEUX, solution for injection 10 ampoules of 5 ml
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYLOCARD 20 mg/ml INTRAVEINEUX, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Dec 2006
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- For professional use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65528593CIP73749709CIP133400937497091Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 20 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.